{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:10:16Z","timestamp":1791666616825,"version":"4.3.4"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"am","delay-in-days":314,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.pharmthera.2023.108467","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T11:30:19Z","timestamp":1685964619000},"page":"108467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Inflammation, lipids, and pain in vulvar disease"],"prefix":"10.1016","volume":"248","author":[{"given":"Megan L.","family":"Falsetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna Rao","family":"Maddipati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth V.","family":"Honn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2023.108467_bb0005","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.biopha.2016.10.017","article-title":"6-Methoxyflavanone attenuates mechanical allodynia and vulvodynia in the streptozotocin-induced diabetic neuropathic pain","volume":"84","author":"Akbar","year":"2016","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108467_bb0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-0035-1554919","article-title":"Vulvodynia: The role of inflammation in the etiology of localized provoked pain of the vulvar vestibule (Vestibulodynia)","volume":"33","author":"Akopians","year":"2015","journal-title":"Seminars in Reproductive Medicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108467_bb0015","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00210-015-1145-y","article-title":"A streptozotocin-induced diabetic neuropathic pain model for static or dynamic mechanical allodynia and vulvodynia: Validation using topical and systemic gabapentin","volume":"388","author":"Ali","year":"2015","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2014.06.002","article-title":"Candida albicans promotes invasion and colonisation of Candida glabrata in a reconstituted human vaginal epithelium","author":"Alves","year":"2014","journal-title":"The Journal of Infection"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12906-016-1048-6","article-title":"Passiflora incarnata attenuation of neuropathic allodynia and vulvodynia apropos GABA-ergic and opioidergic antinociceptive and behavioural mechanisms","volume":"16","author":"Aman","year":"2016","journal-title":"BMC Complementary and Alternative Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108467_bb0030","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/OGX.0b013e3182277fb7","article-title":"Vulvodynia interventions--systematic review and evidence grading","volume":"66","author":"Andrews","year":"2011","journal-title":"Obstetrical & Gynecological Survey"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108467_bb0035","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/01.AOG.0000199951.26822.27","article-title":"Vulvodynia: Characteristics and associations with comorbidities and quality of life","volume":"107","author":"Arnold","year":"2006","journal-title":"Obstetrics and Gynecology"},{"issue":"21","key":"10.1016\/j.pharmthera.2023.108467_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215361","article-title":"Repeated vaginal exposures to the common cosmetic and household preservative methylisothiazolinone induce persistent, mast cell-dependent genital pain in ND4 mice","volume":"20","author":"Arriaga-Gomez","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0045","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.2147\/JIR.S367193","article-title":"Characterization of early inflammatory events leading to provoked vulvodynia development in rats","volume":"15","author":"Awad-Igbaria","year":"2022","journal-title":"Journal of Inflammation Research"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2023.108467_bb0050","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1097\/01.AOG.0000483621.23062.8f","article-title":"Inflammatory markers in vestibulodynia","volume":"127","author":"Baker","year":"2016","journal-title":"Obstetrics and Gynecology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108467_bb0055","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1476-5381.2011.01568.x","article-title":"17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception","volume":"165","author":"Bang","year":"2012","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108467_bb0060","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1476-5381.2010.00909.x","article-title":"Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception","volume":"161","author":"Bang","year":"2010","journal-title":"British Journal of Pharmacology"},{"issue":"186","key":"10.1016\/j.pharmthera.2023.108467_bb0065","article-title":"Emerging evidence of macrophage contribution to hyperinnervation and nociceptor sensitization in vulvodynia","volume":"12","author":"Barry","year":"2019","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108467_bb0070","doi-asserted-by":"crossref","first-page":"10522","DOI":"10.1038\/s41598-017-11274-1","article-title":"Structural determinants of 5\u2032,6\u2032-epoxyeicosatrienoic acid binding to and activation of TRPV4 channel","volume":"7","author":"Berna-Erro","year":"2017","journal-title":"Scientific Reports"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108467_bb0075","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3109\/00016349.2010.528368","article-title":"Medical and physical predictors of localized provoked vulvodynia","volume":"89","author":"Bohm-Starke","year":"2010","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108467_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092163","article-title":"Tetrahydrocannabinol reduces hapten-driven mast cell accumulation and persistent tactile sensitivity in mouse model of allergen-provoked localized vulvodynia","volume":"20","author":"Boo","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108467_bb0085","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jsxm.2016.02.167","article-title":"2015 ISSVD, ISSWSH, and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia","volume":"13","author":"Bornstein","year":"2016","journal-title":"The Journal of Sexual Medicine"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fcimb.2012.00142","article-title":"Fungal pathogens-a sweet and sour treat for toll-like receptors","volume":"2","author":"Bourgeois","year":"2012","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108467_bb0095","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.immuni.2014.02.009","article-title":"Proresolving lipid mediators and mechanisms in the resolution of acute inflammation","volume":"40","author":"Buckley","year":"2014","journal-title":"Immunity."},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108467_bb0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nri3362","article-title":"The resolution of inflammation","volume":"13","author":"Buckley","year":"2013","journal-title":"Nature Reviews. Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108467_bb0105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004347-199801000-00002","article-title":"Histopathologic features of vulvar vestibulitis","volume":"17","author":"Chadha","year":"1998","journal-title":"International Journal of Gynecological Pathology: Official Journal of the International Society of Gynecological Pathologists"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108467_bb0110","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/MMBR.00032-07","article-title":"Candida albicans cell wall proteins","volume":"72","author":"Chaffin","year":"2008","journal-title":"Microbiology and Molecular Biology Reviews"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0115","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mam.2017.03.005","article-title":"Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors","volume":"58","author":"Chiang","year":"2017","journal-title":"Molecular Aspects of Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108467_bb0120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/EBC20200018","article-title":"Specialized pro-resolving mediator network: An update on production and actions","volume":"64","author":"Chiang","year":"2020","journal-title":"Essays in Biochemistry"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108467_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076159","article-title":"IL-27 enhances the expression of TRAIL and TLR3 in human melanomas and inhibits their tumor growth in cooperation with a TLR3 agonist poly(I:C) partly in a TRAIL-dependent manner","volume":"8","author":"Chiba","year":"2013","journal-title":"PLoS One"},{"issue":"353","key":"10.1016\/j.pharmthera.2023.108467_bb0130","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf7483","article-title":"Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses","volume":"8","author":"Chiurchiu","year":"2016","journal-title":"Science Translational Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108467_bb0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5966\/sctm.2015-0163","article-title":"Human periodontal stem cells release specialized proresolving mediators and carry immunomodulatory and prohealing properties regulated by lipoxins","volume":"5","author":"Cianci","year":"2016","journal-title":"Stem Cells Translational Medicine"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108467_bb0140","doi-asserted-by":"crossref","DOI":"10.1152\/ajplung.00125.2015","article-title":"Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages","volume":"309","author":"Croasdell","year":"2015","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108467_bb0145","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.ajpath.2019.07.011","article-title":"Proresolving mediators LXB4 and RvE1 regulate inflammation in stromal cells from patients with shoulder tendon tears","volume":"189","author":"Dakin","year":"2019","journal-title":"The American Journal of Pathology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108467_bb0150","first-page":"423","article-title":"Current perspectives in vulvodynia","volume":"5","author":"Damsted-Petersen","year":"2009","journal-title":"Women\u2019s Health"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108467_bb0155","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1529-8019.2010.01352.x","article-title":"Approach to the diagnosis and treatment of vulvar pain","volume":"23","author":"Danby","year":"2010","journal-title":"Dermatologic Therapy"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.biocel.2016.07.012","article-title":"Modulation of TRPV4 by diverse mechanisms","volume":"78","author":"Darby","year":"2016","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108467_bb0165","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.jsxm.2017.10.072","article-title":"The vulvar pain assessment questionnaire: Factor structure, preliminary norms, internal consistency, and test-retest reliability","volume":"14","author":"Dargie","year":"2017","journal-title":"The Journal of Sexual Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108467_bb0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mehy.2011.09.030","article-title":"Characteristics of the pain observed in the focal vulvodynia syndrome (VVS)","volume":"78","author":"Donders","year":"2012","journal-title":"Medical Hypotheses"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108467_bb0175","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.bcp.2006.07.010","article-title":"Toll-like receptors: From the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity","volume":"72","author":"Doyle","year":"2006","journal-title":"Biochemical Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108467_bb0180","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000087104","article-title":"Cytokine dysregulation, inflammation and well-being","volume":"12","author":"Elenkov","year":"2005","journal-title":"Neuroimmunomodulation."},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108467_bb0185","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0166-2236(97)01138-7","article-title":"Mechanisms of CNS response to systemic immune challenge: The febrile response","volume":"20","author":"Elmquist","year":"1997","journal-title":"Trends in Neurosciences"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108467_bb0190","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.bpobgyn.2014.07.009","article-title":"Vulvodynia","volume":"28","author":"Eppsteiner","year":"2014","journal-title":"Best Practice & Research. Clinical Obstetrics & Gynaecology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108467_bb0195","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/1471-0528.14157","article-title":"A review of the available clinical therapies for vulvodynia management and new data implicating proinflammatory mediators in pain elicitation","volume":"124","author":"Falsetta","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpain.2016.07.007","article-title":"A role for bradykinin signaling in chronic vulvar pain","author":"Falsetta","year":"2016","journal-title":"The Journal of Pain: Official Journal of the American Pain Society"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.02.002","article-title":"Identification of novel mechanisms involved in generating localized vulvodynia pain","author":"Falsetta","year":"2015","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108467_bb0210","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/LGT.0000000000000364","article-title":"Toll-like receptor signaling contributes to proinflammatory mediator production in localized provoked vulvodynia","volume":"22","author":"Falsetta","year":"2018","journal-title":"Journal of Lower Genital Tract Disease"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108467_bb0215","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jpain.2021.03.144","article-title":"Specialized pro-resolving mediators reduce pro-nociceptive inflammatory mediator production in models of localized provoked vulvodynia","volume":"22","author":"Falsetta","year":"2021","journal-title":"The Journal of Pain: Official Journal of the American Pain Society"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108467_bb0220","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00404-005-0079-x","article-title":"Lifetime changes in the vulva and vagina","volume":"273","author":"Farage","year":"2006","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"101","key":"10.1016\/j.pharmthera.2023.108467_bb0225","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002613","article-title":"Repeated vulvovaginal fungal infections cause persistent pain in a mouse model of vulvodynia","volume":"3","author":"Farmer","year":"2011","journal-title":"Science Translational Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108467_bb0230","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1396-0296.2004.04014.x","article-title":"Management of vulvar pain","volume":"17","author":"Fischer","year":"2004","journal-title":"Dermatologic Therapy"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0235","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/JIR.S142424","article-title":"Comparative effects of the omega3 polyunsaturated fatty acid derivatives resolvins E1 and D1 and protectin DX in models of inflammation and pain","volume":"10","author":"Fonseca","year":"2017","journal-title":"Journal of Inflammation Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108467_bb0240","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/01.j.pain.0000460320.95267.5d","article-title":"Site-specific mesenchymal control of inflammatory pain to yeast challenge in vulvodynia afflicted and pain-free women","volume":"156","author":"Foster","year":"2015","journal-title":"Pain."},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108467_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2006.12.038","article-title":"Enhanced synthesis of proinflammatory cytokines by vulvar vestibular fibroblasts: Implications for vulvar vestibulitis","volume":"196","author":"Foster","year":"2007","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108467_bb0250","first-page":"773","article-title":"The vulvar vestibule","volume":"28","author":"Friedrich","year":"1983","journal-title":"The Journal of Reproductive Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108467_bb0255","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1084\/jem.20021787","article-title":"Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2","volume":"197","author":"Gantner","year":"2003","journal-title":"The Journal of Experimental Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108467_bb0260","first-page":"413","article-title":"Vaginal colonization by Candida in asymptomatic women with and without a history of recurrent vulvovaginal candidiasis","volume":"95","author":"Giraldo","year":"2000","journal-title":"Obstetrics and Gynecology"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108467_bb0265","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1111\/jsm.12668","article-title":"Polymorphisms of the androgen receptor gene and hormonal contraceptive induced provoked vestibulodynia","volume":"11","author":"Goldstein","year":"2014","journal-title":"The Journal of Sexual Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108467_bb0270","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrmicro2711","article-title":"Candida albicans morphogenesis and host defence: Discriminating invasion from colonization","volume":"10","author":"Gow","year":"2012","journal-title":"Nature Reviews. Microbiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108467_bb0275","first-page":"500","article-title":"Hyperoxaluria in women with vulvar vestibulitis syndrome","volume":"51","author":"Greenstein","year":"2006","journal-title":"The Journal of Reproductive Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108467_bb0280","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.det.2010.07.002","article-title":"Vulvodynia: New concepts and review of the literature","volume":"28","author":"Groysman","year":"2010","journal-title":"Dermatologic Clinics"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108467_bb0285","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00128360-200501000-00009","article-title":"The vulvodynia guideline","volume":"9","author":"Haefner","year":"2005","journal-title":"Journal of Lower Genital Tract Disease"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108467_bb0290","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1021\/acs.jmedchem.0c01886","article-title":"Movement to the clinic of soluble epoxide hydrolase inhibitor EC5026 as an analgesic for neuropathic pain and for use as a nonaddictive opioid alternative","volume":"64","author":"Hammock","year":"2021","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108467_bb0295","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/1871526515666150320162036","article-title":"Candidiasis: A fungal infection--current challenges and progress in prevention and treatment","volume":"15","author":"Hani","year":"2015","journal-title":"Infectious Disorders Drug Targets"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108467_bb0300","first-page":"171","article-title":"Influence of dietary oxalates on the risk of adult-onset vulvodynia","volume":"53","author":"Harlow","year":"2008","journal-title":"The Journal of Reproductive Medicine"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108467_bb0305","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1089\/jwh.2016.5777","article-title":"Recurrent yeast infections and vulvodynia: can we believe associations based on self-reported data?","volume":"26","author":"Harlow","year":"2017","journal-title":"Journal of Women\u2019s Health"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108467_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2013.09.033","article-title":"Prevalence of symptoms consistent with a diagnosis of vulvodynia: Population-based estimates from 2 geographic regions","volume":"210","author":"Harlow","year":"2014","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108467_bb0315","first-page":"82","article-title":"A population-based assessment of chronic unexplained vulvar pain: Have we underestimated the prevalence of vulvodynia?","volume":"58","author":"Harlow","year":"2003","journal-title":"Journal of the American Medical Women\u2019s Association"},{"issue":"Pt 12","key":"10.1016\/j.pharmthera.2023.108467_bb0320","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1099\/mic.0.039354-0","article-title":"Candida albicans forms biofilms on the vaginal mucosa","volume":"156","author":"Harriott","year":"2010","journal-title":"Microbiology."},{"key":"10.1016\/j.pharmthera.2023.108467_bb0325","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917704138","article-title":"Prostanoid-dependent spontaneous pain and PAR2-dependent mechanical allodynia following oral mucosal trauma: involvement of TRPV1, TRPA1 and TRPV4","volume":"13","author":"Ito","year":"2017","journal-title":"Molecular Pain"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108467_bb0330","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4111\/kju.2013.54.1.48","article-title":"A retrospective study of the management of vulvodynia","volume":"54","author":"Jeon","year":"2013","journal-title":"Korean Journal of Urology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108467_bb0335","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0002-9378(00)70212-2","article-title":"Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis","volume":"182","author":"Jeremias","year":"2000","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0340","first-page":"5259321","article-title":"Resolvin E1 inhibits substance P-induced potentiation of TRPV1 in primary sensory neurons","author":"Jo","year":"2016","journal-title":"Mediators of Inflammation"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108467_bb0345","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/LGT.0000000000000445","article-title":"Localized provoked vulvodynia: Association with nerve growth factor and transient receptor potential vanilloid type 1 genes polymorphisms","volume":"23","author":"Kalfon","year":"2019","journal-title":"Journal of Lower Genital Tract Disease"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108467_bb0350","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1111\/bph.12414","article-title":"Transient receptor potential (TRP) channels: a clinical perspective","volume":"171","author":"Kaneko","year":"2014","journal-title":"British Journal of Pharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108467_bb0355","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1248\/bpb.34.1170","article-title":"Prostaglandin E2 and pain--an update","volume":"34","author":"Kawabata","year":"2011","journal-title":"Biological & Pharmaceutical Bulletin"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108467_bb0360","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1751-486X.2009.01373.x","article-title":"Vulvodynia: A comprehensive review","volume":"13","author":"Kingdon","year":"2009","journal-title":"Nursing for Women\u2019s Health"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108467_bb0365","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1089\/jwh.2018.7352","article-title":"Female sexual health: Barriers to optimal outcomes and a roadmap for improved patient-clinician communications","volume":"28","author":"Kingsberg","year":"2019","journal-title":"Journal of Women\u2019s Health"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108467_bb0370","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00228-010-0906-2","article-title":"Systemic uptake of miconazole during vaginal suppository use and effect on CYP1A2 and CYP3A4 associated enzyme activities in women","volume":"66","author":"Kjaerstad","year":"2010","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108467_bb0375","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neulet.2010.05.036","article-title":"Peripheral and central cyclooxygenase (COX) products may contribute to the manifestation of brain-controlled sickness responses during localized inflammation induced by macrophage-activating lipopeptide-2 (MALP-2)","volume":"479","author":"Knorr","year":"2010","journal-title":"Neuroscience Letters"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108467_bb0380","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108467_bb0385","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/AOG.0b013e31821c33dc","article-title":"Differences in primary compared with secondary vestibulodynia by immunohistochemistry","volume":"117","author":"Leclair","year":"2011","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108467_bb0390","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/LGT.0b013e3182a55591","article-title":"CD4-positive T-cell recruitment in primary-provoked localized vulvodynia: Potential insights into disease triggers","volume":"18","author":"Leclair","year":"2014","journal-title":"Journal of Lower Genital Tract Disease"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0395","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev-physiol-021113-170408","article-title":"Resolution of acute inflammation in the lung","volume":"76","author":"Levy","year":"2014","journal-title":"Annual Review of Physiology"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108467_bb0400","first-page":"493","article-title":"The use of over-the-counter antifungal vaginitis preparations by college students","volume":"28","author":"Lipsky","year":"1996","journal-title":"Family Medicine"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0405","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3389\/fphar.2019.00745","article-title":"Resolvin D5 inhibits neuropathic and inflammatory pain in male but not female mice: Distinct actions of D-series resolvins in chemotherapy-induced peripheral neuropathy","volume":"10","author":"Luo","year":"2019","journal-title":"Frontiers in Pharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108467_bb0410","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ptr.3171","article-title":"NFkappaB: A promising target for natural products in cancer chemoprevention","volume":"24","author":"Luqman","year":"2010","journal-title":"Phytotherapy Research: PTR"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0415","doi-asserted-by":"crossref","first-page":"580117","DOI":"10.3389\/fimmu.2020.580117","article-title":"Non-inflammatory physiology of \u201cinflammatory\u201d mediators - unalamation, a new paradigm","volume":"11","author":"Maddipati","year":"2020","journal-title":"Frontiers in Immunology"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2023.108467_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1439-0507.2012.02185.x","volume":"55","author":"Mendling","year":"2012","journal-title":"Mycoses"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0425","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/bs.pmbts.2015.01.002","article-title":"Sensory TRP channels: The key transducers of nociception and pain","volume":"131","author":"Mickle","year":"2015","journal-title":"Progress in Molecular Biology and Translational Science"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108467_bb0430","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrn2606","article-title":"Animal models of pain: Progress and challenges","volume":"10","author":"Mogil","year":"2009","journal-title":"Nature Reviews. Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108467_bb0435","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12264-017-0200-8","article-title":"Regulation of pain and itch by TRP channels","volume":"34","author":"Moore","year":"2018","journal-title":"Neuroscience Bulletin"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108467_bb0440","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1111\/bph.14044","article-title":"Targeting nociceptive transient receptor potential channels to treat chronic pain: current state of the field","volume":"175","author":"Moran","year":"2018","journal-title":"British Journal of Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108467_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.11.019","article-title":"Familiality analysis of provoked vestibulodynia treated by vestibulectomy supports genetic predisposition","volume":"214","author":"Morgan","year":"2016","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108467_bb0450","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/jps.2600550421","article-title":"Analgesic and local anesthetic activity of dimethyl sulfoxide","volume":"55","author":"Morris","year":"1966","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108467_bb0455","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1086\/651200","article-title":"Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan","volume":"202","author":"Nett","year":"2010","journal-title":"The Journal of Infectious Diseases"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108467_bb0460","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/pme.12151","article-title":"Perceived stereotyping and seeking care for chronic vulvar pain","volume":"14","author":"Nguyen","year":"2013","journal-title":"Pain Medicine"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0465","author":"NIH"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108467_bb0470","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1365-2133.2010.09684.x","article-title":"Guidelines for the management of vulvodynia","volume":"162","author":"Nunns","year":"2010","journal-title":"The British Journal of Dermatology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108467_bb0475","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1743-6109.2007.00430.x","article-title":"Sexual medicine education: Review and commentary","volume":"4","author":"Parish","year":"2007","journal-title":"The Journal of Sexual Medicine"},{"issue":"50","key":"10.1016\/j.pharmthera.2023.108467_bb0480","doi-asserted-by":"crossref","first-page":"18433","DOI":"10.1523\/JNEUROSCI.4192-11.2011","article-title":"Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1\/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1","volume":"31","author":"Park","year":"2011","journal-title":"The Journal of Neuroscience"},{"issue":"14","key":"10.1016\/j.pharmthera.2023.108467_bb0485","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145019","article-title":"Resolvin D1 and D2 inhibit transient receptor potential Vanilloid 1 and Ankyrin 1 ion channel activation on sensory neurons via lipid raft modification","volume":"21","author":"Payrits","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108467_bb0490","doi-asserted-by":"crossref","first-page":"E647","DOI":"10.1152\/ajpendo.00227.2009","article-title":"Detection of EETs and HETE-generating cytochrome P-450 enzymes and the effects of their metabolites on myometrial and vascular function","volume":"297","author":"Pearson","year":"2009","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108467_bb0495","first-page":"369","article-title":"Sleeping sickness and the central nervous system","volume":"61","author":"Pentreath","year":"1994","journal-title":"The Onderstepoort Journal of Veterinary Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108467_bb0500","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.bbi.2004.01.004","article-title":"The influence of systemic inflammation on inflammation in the brain: Implications for chronic neurodegenerative disease","volume":"18","author":"Perry","year":"2004","journal-title":"Brain, Behavior, and Immunity"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108467_bb0505","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00401-010-0722-x","article-title":"Contribution of systemic inflammation to chronic neurodegeneration","volume":"120","author":"Perry","year":"2010","journal-title":"Acta Neuropathologica"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108467_bb0510","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/IAI.01417-13","article-title":"Fungal morphogenetic pathways are required for the hallmark inflammatory response during Candida albicans vaginitis","volume":"82","author":"Peters","year":"2014","journal-title":"Infection and Immunity"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108467_bb0515","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1097\/j.pain.0000000000000264","article-title":"Neonatal vaginal irritation results in long-term visceral and somatic hypersensitivity and increased hypothalamic-pituitary-adrenal axis output in female mice","volume":"156","author":"Pierce","year":"2015","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108467_bb0520","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1074\/jbc.M112.438184","article-title":"Protease-activated receptor 2 (PAR2) protein and transient receptor potential vanilloid 4 (TRPV4) protein coupling is required for sustained inflammatory signaling","volume":"288","author":"Poole","year":"2013","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108467_bb0525","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jsxm.2015.12.021","article-title":"Vulvodynia: Definition, prevalence, impact, and pathophysiological factors","volume":"13","author":"Pukall","year":"2016","journal-title":"The Journal of Sexual Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108467_bb0530","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.0105-1873.2005.00685.x","article-title":"Cutaneous hypersensitivity to Candida albicans in idiopathic vulvodynia","volume":"53","author":"Ramirez De Knott","year":"2005","journal-title":"Contact Dermatitis"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108467_bb0535","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1208\/s12249-021-01969-0","article-title":"Chemotherapeutic agent-induced vulvodynia, an experimental model","volume":"22","author":"Rangappa","year":"2021","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108467_bb0540","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/jsm.12775","article-title":"Genetic differences may reflect differences in susceptibility to vulvodynia in general or in spontaneous remission propensity","volume":"12","author":"Reed","year":"2015","journal-title":"The Journal of Sexual Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108467_bb0545","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/AOG.0b013e31825957cf","article-title":"Relationship between vulvodynia and chronic comorbid pain conditions","volume":"120","author":"Reed","year":"2012","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108467_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.08.012","article-title":"Prevalence and demographic characteristics of vulvodynia in a population-based sample","volume":"206","author":"Reed","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2 Pt 1","key":"10.1016\/j.pharmthera.2023.108467_bb0555","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/AOG.0000000000000066","article-title":"Factors associated with vulvodynia incidence","volume":"123","author":"Reed","year":"2014","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108467_bb0560","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/LGT.0000000000000377","article-title":"Nerve growth factor and selected cytokines in women with and without vulvodynia","volume":"22","author":"Reed","year":"2018","journal-title":"Journal of Lower Genital Tract Disease"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108467_bb0565","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1172\/JCI23618","article-title":"Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype","volume":"115","author":"Reinold","year":"2005","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108467_bb0570","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40265-019-01085-1","article-title":"Treatment of vulvodynia: Pharmacological and non-pharmacological approaches","volume":"79","author":"Rosen","year":"2019","journal-title":"Drugs."},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108467_bb0575","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.jsxm.2018.08.008","article-title":"Best practices in North American pre-clinical medical education in sexual history taking: Consensus from the summits in medical education in sexual health","volume":"15","author":"Rubin","year":"2018","journal-title":"The Journal of Sexual Medicine"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0580","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2147\/IJWH.S37660","article-title":"Etiology, diagnosis, and clinical management of vulvodynia","volume":"6","author":"Sadownik","year":"2014","journal-title":"International Journal of Women\u2019s Health"},{"issue":"7503","key":"10.1016\/j.pharmthera.2023.108467_bb0585","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature."},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108467_bb0590","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1096\/fj.201601222R","article-title":"Treating inflammation and infection in the 21st century: New hints from decoding resolution mediators and mechanisms","volume":"31","author":"Serhan","year":"2017","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2017.03.001","article-title":"Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology","volume":"58","author":"Serhan","year":"2017","journal-title":"Molecular Aspects of Medicine"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2015.03.004","article-title":"The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution","author":"Serhan","year":"2015","journal-title":"Seminars in Immunology"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2017.08.002","article-title":"New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration","volume":"64","author":"Serhan","year":"2018","journal-title":"Molecular Aspects of Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108467_bb0610","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016311","article-title":"Lipid mediators in the resolution of inflammation","volume":"7","author":"Serhan","year":"2014","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108467_bb0615","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1096\/fj.11-201442","article-title":"Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain","volume":"26","author":"Serhan","year":"2012","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0620","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.plefa.2016.03.001","article-title":"Beyond the classic eicosanoids: Peripherally-acting oxygenated metabolites of polyunsaturated fatty acids mediate pain associated with tissue injury and inflammation","volume":"111","author":"Shapiro","year":"2016","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108467_bb0625","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1743-6109.2012.02987.x","article-title":"Sexuality education in North American medical schools: Current status and future directions","volume":"10","author":"Shindel","year":"2013","journal-title":"The Journal of Sexual Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108467_bb0630","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/YCO.0000000000000098","article-title":"Female sexual pain disorders: Dyspareunia and vaginismus","volume":"27","author":"Simonelli","year":"2014","journal-title":"Current Opinion in Psychiatry"},{"issue":"Suppl. 5","key":"10.1016\/j.pharmthera.2023.108467_bb0635","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1038\/sj.ijir.3901071","article-title":"The human sexuality education of physicians in North American medical schools","volume":"15","author":"Solursh","year":"2003","journal-title":"International Journal of Impotence Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108467_bb0640","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1743-6109.2010.01941.x","article-title":"Long-term results of an individualized, multifaceted, and multidisciplinary therapeutic approach to provoked vestibulodynia","volume":"8","author":"Spoelstra","year":"2011","journal-title":"The Journal of Sexual Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108467_bb0645","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ogc.2017.05.008","article-title":"Vulvodynia: Diagnosis and management","volume":"44","author":"Stenson","year":"2017","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108467_bb0650","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/LGT.0000000000000021","article-title":"2013 Vulvodynia guideline update","volume":"18","author":"Stockdale","year":"2014","journal-title":"Journal of Lower Genital Tract Disease"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108467_bb0655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002848","article-title":"A Candida biofilm-induced pathway for matrix glucan delivery: Implications for drug resistance","volume":"8","author":"Taff","year":"2012","journal-title":"PLoS Pathogens"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108467_bb0660","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s13311-020-00892-9","article-title":"Neuromodulation, specialized proresolving mediators, and resolution of pain","volume":"17","author":"Tao","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0665","first-page":"605101","article-title":"Anti-inflammatory effects of epoxyeicosatrienoic acids","author":"Thomson","year":"2012","journal-title":"International Journal of Vascular Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108467_bb0670","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/archdermatol.2010.443","article-title":"Successful treatment of vulvodynia with botulinum toxin A","volume":"147","author":"Tieu","year":"2011","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108467_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.10.1098","article-title":"Activation of vestibule-associated lymphoid tissue in localized provoked vulvodynia","volume":"212","author":"Tommola","year":"2015","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108467_bb0680","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3109\/00016349.2010.512071","article-title":"Surgical treatment of vulvar vestibulitis: A review","volume":"89","author":"Tommola","year":"2010","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108467_bb0685","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1600-0412.2011.01248.x","article-title":"Long-term follow up of posterior vestibulectomy for treating vulvar vestibulitis","volume":"90","author":"Tommola","year":"2011","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108467_bb0690","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1600-0412.2012.01466.x","article-title":"Long-term well-being after surgical or conservative treatment of severe vulvar vestibulitis","volume":"91","author":"Tommola","year":"2012","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108467_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.07.037","article-title":"Immune activation enhances epithelial nerve growth in provoked vestibulodynia","volume":"215","author":"Tommola","year":"2016","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108467_bb0700","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1161\/01.RES.0000187474.47805.30","article-title":"Modulation of the Ca2 permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium","volume":"97","author":"Vriens","year":"2005","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108467_bb0710","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbr.2011.02.028","article-title":"Nuclear factor-kappa B mediates TRPV4-NO pathway involved in thermal hyperalgesia following chronic compression of the dorsal root ganglion in rats","volume":"221","author":"Wang","year":"2011","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.pain.2014.05.010","article-title":"Vulvodynia: Current state of the biological science","author":"Wesselmann","year":"2014","journal-title":"Pain."},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108467_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2019.08.009","article-title":"Surgical management of neuroproliferative-associated vestibulodynia: a tutorial on vestibulectomy with vaginal advancement flap","volume":"221","author":"Wu","year":"2019","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108467_bb0725","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/1471-0528.14415","article-title":"Vulvodynia - a painful condition; an inflammatory process?","volume":"124","author":"Wylie","year":"2017","journal-title":"BJOG: An International Journal of Obstetrics and Gynaecology"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108467_bb0730","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.RES.87.11.992","article-title":"Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids","volume":"87","author":"Yu","year":"2000","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0735","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejogrb.2018.05.035","article-title":"Cytokine profiles of women with vulvodynia: Identification of a panel of pro-inflammatory molecular targets","volume":"226","author":"Zanotta","year":"2018","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108467_bb0740","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.neuroscience.2008.09.038","article-title":"Localized inflammation in peripheral tissue signals the CNS for sickness response in the absence of interleukin-1 and cyclooxygenase-2 in the blood and brain","volume":"157","author":"Zhang","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0745","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3389\/fphar.2018.00412","article-title":"Distinct analgesic actions of DHA and DHA-derived specialized pro-resolving mediators on post-operative pain after bone fracture in mice","volume":"9","author":"Zhang","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108467_bb0750","doi-asserted-by":"crossref","first-page":"110354","DOI":"10.1016\/j.biopha.2020.110354","article-title":"The biological role of arachidonic acid 12-lipoxygenase (ALOX12) in various human diseases","volume":"129","author":"Zheng","year":"2020","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"4\u20135","key":"10.1016\/j.pharmthera.2023.108467_bb0755","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0960-0760(02)00116-4","article-title":"The production of progesterone and 5,6-epoxyeicosatrienoic acid by human granulosa cells","volume":"81","author":"Zosmer","year":"2002","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823001316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823001316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:31:38Z","timestamp":1759012298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725823001316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":150,"alternative-id":["S0163725823001316"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108467","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation, lipids, and pain in vulvar disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108467"}}